CSIMarket
 


Bruker Corporation  (BRKR)
Other Ticker:  
 

Bruker's Working Capital Ratio

BRKR's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Working Capital Ratio fell to 1.89 below Bruker Corporation average.

Within Laboratory Analytical Instruments industry 24 other companies have achieved higher Working Capital Ratio than Bruker in third quarter 2023. While Working Capital Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 1715 to 2224.

Explain Working Capital Ratio
How much in Current Assets BRKR´s has?
What is the value of BRKR´s Current Liabilities?


BRKR Working Capital Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 24.02 % 28.41 % 19.08 % -6.03 % -6.14 %
Y / Y Current Assets Change -0.35 % 4.59 % -5.23 % -14.51 % 2.38 %
Working Capital Ratio MRQ 1.89 2.08 2.03 3.03 2.36
BRKR's Total Ranking # 2224 # 1715 # 2056 # 686 # 2122
Seq. Current Liabilities Change 2.04 % 0.23 % 50.58 % -19.47 % 5.65 %
Seq. Current Assets Change -7.05 % 2.36 % 0.94 % 3.76 % -2.44 %



Working Capital Ratio third quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 25
Healthcare Sector # 734
Overall Market # 2224


Working Capital Ratio Statistics
High Average Low
3.54 2.38 1.58
(Dec 31 2019)   (Dec 31 2011)




Financial Statements
Bruker's Current Liabilities $ 1,072 Millions Visit BRKR's Balance sheet
Bruker's Current Assets $ 2,029 Millions Visit BRKR's Balance sheet
Source of BRKR's Sales Visit BRKR's Sales by Geography


Cumulative Bruker's Working Capital Ratio

BRKR's Working Capital Ratio for the trailling 12 Months

BRKR Working Capital Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 24.02 % 28.41 % 19.08 % -6.03 % -6.14 %
Y / Y Current Assets TTM Growth -0.35 % 4.59 % -5.23 % -14.51 % 2.38 %
Working Capital Ratio TTM 2.19 2.31 2.44 2.6 2.68
Total Ranking TTM # 2370 # 4070 # 1911 # 696 # 3811
Seq. Current Liabilities TTM Growth 2.04 % 0.23 % 50.58 % -19.47 % 5.65 %
Seq. Current Assets TTM Growth -7.05 % 2.36 % 0.94 % 3.76 % -2.44 %


On the trailing twelve months basis Due to rise in Current Liabilities in the III Quarter 2023 to $1,072.30 millions, cumulative Working Capital Ratio decreased to 2.19 below the Bruker Corporation average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 18 other companies have achieved higher Working Capital Ratio than Bruker. While Working Capital Ratio overall ranking has improved so far to 2370, from total ranking during the twelve months ending second quarter 2023 at 4070.

Explain Working Capital Ratio
How much in Current Assets BRKR´s has?
What is the value of BRKR´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 19
Healthcare Sector # 608
Within the Market # 2370


trailing twelve months Working Capital Ratio Statistics
High Average Low
2.66 2.32 2.07
(Sep 30 2020)   (Sep 30 2023)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2023, within Laboratory Analytical Instruments Industry Working Capital RatioSep 30 2023 MRQ Current AssetsSep 30 2023 MRQ Current Liabilities
Pacific Biosciences Of California Inc   4.80 $ 882.297  Millions$ 183.961  Millions
Scientific Industries Inc   3.93 $ 8.572  Millions$ 2.183  Millions
Standard Biotools Inc   3.30 $ 170.741  Millions$ 51.800  Millions
Akoya Biosciences Inc   3.29 $ 116.948  Millions$ 35.523  Millions
Cue Health Inc   3.29 $ 192.239  Millions$ 58.407  Millions
Agilent Technologies inc   2.61 $ 4,186.000  Millions$ 1,603.000  Millions
Bionano Genomics Inc   2.60 $ 104.537  Millions$ 40.194  Millions
Eyepoint Pharmaceuticals Inc   2.35 $ 150.163  Millions$ 63.896  Millions
Kewaunee Scientific Corporation  2.35 $ 90.876  Millions$ 38.732  Millions
Harvard Bioscience Inc  2.09 $ 50.486  Millions$ 24.205  Millions
Revvity Inc   2.01 $ 2,913.237  Millions$ 1,447.845  Millions
Bruker Corporation  1.89 $ 2,029.400  Millions$ 1,072.300  Millions
Illumina Inc   1.69 $ 2,506.000  Millions$ 1,482.000  Millions
Avantor Inc   1.60 $ 2,384.800  Millions$ 1,488.100  Millions
Mettler toledo International Inc   1.34 $ 1,196.912  Millions$ 891.340  Millions
Accelerate Diagnostics Inc   0.86 $ 32.443  Millions$ 37.786  Millions
Precipio inc   0.85 $ 4.309  Millions$ 5.060  Millions
Thermogenesis Holdings Inc   0.78 $ 6.925  Millions$ 8.890  Millions

Date modified: 2023-11-12T10:53:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com